AC Immune SA, a clinical-stage biopharmaceutical company developing targeted therapeutics for neurodegenerative diseases, has announced positive interim results from a Phase 1 study of ACI-19764 – its ...

Join Amiculum for an exclusive live webinar and audience Q&A to gain practical insights from global payer research and ...

Hong Kong biopharma company Akeso has secured clinical trial clearance in China for a next-generation antibody-drug conjugate ...

Paris, France-based Bioptimus, a global AI biotech company, has announced a partnership with Cancer Research Horizons, the ...

Anthropic's Claude Science performed impressively in a protein design exercise, designing binders against 14 out of 15 ...

US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of commissioner ...

Cytokinetics should hear back from the FDA next September about its marketing application for aficamten, which is vying to become the first rival to Bristol-Myers Squibb's fast-growing Camzyos for ...

The Advanced Research Projects Agency for Health (ARPA-H) has awarded Siemens Healthineers up to $31.1 million over five years to accelerate the development of autonomous, remote, endovascular ...

Bristol Myers Squibb and Pfizer have launched an online programme to sell their blockbuster anticoagulant Eliquis directly to patients, following in the footsteps of Eli Lilly and Novo Nordisk in a ...

Kinvard Bio is one of the few companies seriously trying to change that. It started as a scientific spinout from the Andrew ...

But Sohonos has not lived up to its sales potential, despite being the only drug on the market, perhaps owing to relatively ...

More than 20,000 biotechnology leaders gathered in San Diego for the 2026 BIO International Convention under the theme, ...